Bristol-Myers Squibb has notified healthcare professionals about a new boxed warning for the antiviral drug Baraclude (entecavir). Baraclude is approved to treat certain patients with chronic hepatitis B.
The boxed warning says that patients infe...
Lawyer Central Also Recommends These Stories: